Advertisement

Programme of the EAU 9th Central European Meeting (CEM)

        Friday, 23 October 2009

        Tabled 1
        07.30–09.00Registration
        09.00–09.10Welcome
        P.A. Abrahamsson, Malmö (S)
        C. Oblak, Ljubljana (SI)
        09.10–10:30Managing Complications of pelvic radiotherapy
        09.10–10.30Bladder dysfunction
        M. Mihelic, Ljubljana (SI)
        Fistulae, A. Borkowski, Warsaw (PL)
        Recurrent prostate cancer, P.A. Abrahamsson, Malmö (SE)
        Secondary tumors, V. Student, Olomouc (CZ)
        10.30–11.00Coffee break and poster viewing
        Tabled 1
        10.30–12.30Poster session 1: BPH and urinary tract infectionsPoster room 1
        C1.The short-term results of transurethral vaporization of the prostate using plasmakinetic energy – first experience from Czech Republic, J. Klečka*, M. Hora, P. Behounek, P. Toufarova, V. Eret, P. Stránský (Plzen, Czech Republic)
        C2.A retrospective study of the efficacy of tamsulosin, serenoa repens and serenoa repens plus tamsulosin treatment for patients with benign prosatic hyperplasia: The COMBTAMSR study, D. Argirovic*, A. Argirovic (Belgrade, Serbia)
        C3.Multi-disciplinary laser DIOLAS LFD 3000 compared to 80W PVP GreenLight for the treatment of BPH (benign prostate hyperplasia), J. Neymeyer*, T. Wuelfing, W. Abdul-Wahab Al-Ansari, A. Apostolidis, M. Beer (Berlin, Germany)
        C4.Multi-disciplinary laser DIOLAS LFD 3000 in daily clinical use for the treatment of BPH (benign prostate hyperplasia), stones, strictures and condylomata, J. Neymeyer*, T. Wuelfing, C. Baecker, A. Apostolidis, M. Beer (Berlin, Germany)
        C5.The impact of median lobe in benign prostatic hyperplasia on severity of lower urinary tract symptoms and PSA levels: Controlled, clinical study, M. Kadihasanoglu, M.S. Silay*, O. Tanriverdi, M. Aydın, C. Miroglu, M. Kendirci (Istanbul, Turkey)
        C6.Are there any factors predicting the postoperative complications of transurethral resection of the prostate?, P. Rotariu, V. Petcu* (Cluj-Napoca, Cluj-napoca, Romania)
        C7.Serum HPV antibodies in prostate cancer and benign prostatic hyperplasia patients, J. Hrbáček*, J. Heráček, E. Hamsikova, R. Tachezy, V. Eis, M. Urban (Prague, Czech Republic)
        C8.Impact of finasteride on perioperative bleeding before transurethral vapor resection of the prostate, D. Argirovic*, A. Argirovic (Belgrade, Serbia)
        C9.First Romanian experience with TURIS plasma vaporization in BPH, B. Geavlete*, M. Dragutescu, R. Multescu, D. Georgescu, M. Jecu, P. Geavlete (Bucharest, Romania)
        C10.Beneficial effects of cranberries on prostate health: Evidence from a randomized controlled trial, A. Vidlar*, J. Vostalova, J. Ulrichova, V. Student, D. Stejskal, R. Reichenbach, J. Vrbkova, F. Ruzicka, V. Simanek (Olomouc, Prostêjov, Třinec, Brno, Czech Republic)
        C11.Is treatment of haemorrhagic radiation cystitis with hyperbaric oxygen (HBO) effective?, B. Mohamad Al-Ali*, K. Pummer (Graz, Austria)
        C12.Investigating the significance of phosphodiesterase (PDE) isoenzymes in the control of the human detrusor – a functional and molecular biology approach, S. Ückert*, P. Sandner, E. Ulbrich, M.A. Kuczyk (Hannover, Wuppertal, Leverkusen, Germany)
        C13.Incidence of urinary tract infections in children with neurogenic bladder, M.S. Silay*, O. Tanriverdi, T. Karatag, M. Aydın, K. Horasanli, C. Miroglu (Istanbul, Turkey)
        C14.Genitourinary tuberculosis in Czech Republic – data of 2008, P. Nencka*, R. Zachoval, V. Vik, M. Záleský, M. Galas, V. Borovička (Prague, Czech Republic)
        C15.Role of procalcitonine in diagnostics of acute pyelonephritis, P. Nencka*, R. Zachoval, M. Záleský, V. Vik, M. Galas, V. Borovička, P. Holy (Prague, Czech Republic)
        C16.The significance of urethral calibration and uroflowmetry in the evaluation of the subvesical obstruction in women suffering from recurrent urinary tract infections, V. Borovička*, R. Zachoval, P. Holy, P. Nencka (Prague, Czech Republic)
        Tabled 1
        10.30–12.30Poster session 2: IncontinencePoster room 2
        C17.SPARC success based on body mass index, E. Puchwein*, K. Pummer, G. Primus (Graz, Austria)
        C18.Quality of life after SPARC-sling procedure: a long term outcome survey, E. Puchwein*, S. Heidler, K. Pummer, G. Primus (Graz, Austria)
        C19.Long-term outcome of the SPARC-sling system, E. Puchwein*, S. Heidler, K. Pummer, G. Primus (Graz, Austria)
        C20.Transurethral collagen injection in patients with stress urinary incontinence after prostatic surgery – a 10 year single centre experience, C. Persu*, V. Cauni, P.A. Geavlete (Bucharest, Romania)
        C21.Botulinum toxin (BTX)- and guanethidine-induced changes at chemical coding of paracervical ganglion (PCG) neurons supplying porcine urinary bladder, A. Bossowska*, E. Lepiarczyk, P. Radziszewski, A. Borkowski, M. Majewski (Olsztyn, Warsaw, Poland)
        C22.Minimally invasive surgical treatment of complex genital prolapse in elderly women – impact on quality of life, B.C. Chibelean*, C. Moldovan, C. Surcel, C. Necoara, R. Stoica, C. Gingu, C. Savu, M. Harza, I. Sinescu (Bucharest, Romania)
        C23.The influence of botulinum toxin (BTX) and guanethidine on the adrenergic (sympathetic) and cholinergic (parasympathetic) innervation pattern of the porcine urinary bladder wall, E. Lepiarczyk*, A. Bossowska, J. Wojtkiewicz, A. Borkowski, P. Radziszewski, M. Majewski (Olsztyn, Warsaw, Poland)
        C24.Complications after incontinence surgery in female patients, A. Majoros*, A. Keszthelyi, A. Hamvas, I. Romics (Budapest, Hungary)
        C25.Epidemiology of urinary incontinence in Romania – Omnibus study, C. Surcel*, C. Chibelean, C. Mirvald, C. Gingu, D. Avram, V. Cerempei, M. Harza, M.A. Manu, C. Savu, I. Sinescu (Bucharest, Romania)
        C26.The treatment of the stress urinary incontinence using the “tension free” transvaginal or transobturatory tapes – the experience of the Urology Clinic of “Prof. Dr. Th. Burghele” Clinical Hospital, Bucharest, Romania between 2004–2008, I. Ambert*, M.T. Radu, T.V. Constantin, V. Jinga, D. Badescu (Bucharest, Romania)
        C27.The role of The Urgencymetry 1.0 in the evaluation of the urinary urgency in females, J. Svihra*, J. Luptak, J. Kliment, J. Vasil, P. Brenisin, V. Kovacik, L. Macko, L. Skladany (Martin, Poprad, Liptovsky Mikulas, Levice, Slovakia)
        C28.A comparison between the complication rates of titanium coated TVT and titanium coated TVT-O sub-urethral meshes: A prospective study, J. Neymeyer*, W. Abdul-Wahab Al-Ansari, C. Baecker, B. Mueller, M. Abou-Dakn, A. Al-Yafaey, M. Beer (Berlin, Germany; Manama, Bahrain)
        C29.Titanium coated extralight mesh (TiLOOP – TiFour) for treatment of vaginal vault prolapse: A prospective randomized study, J. Neymeyer*, T. Wuelfing, W. Abdul-Wahab Al-Ansari, C. Baecker, M. Beer (Berlin, Germany)
        C30.Late results of InVance sling procedure for male stress urinary incontinence, D. Bratuš*, G. Hlebič, T. Hajdinjak, N. Kavcic, M.K. Rebek, U. Kacjan (Maribor, Slovenia)
        C31.The relationship of patients perceive urgency sense severity on overactive bladder symptom score and cystometric findings, G. Temeltas*, I. Celen, T. Muezzinoglu, M. Lekili (Manisa, Turkey)
        Tabled 1
        10.30–12.30Poster session 3: Andrology and Testicular tumorsPoster room 3
        C32.The difference in treatment efficacy between long-acting and short-acting PDE5 inhibitors in patients with erectile dysfunction, J. Bizjak*, I. Bizjak, S. Hawlina, C. Oblak, K. Jagodič (Ljubljana, Celje, Slovenia)
        C33.Prediction of the severity of erectile dysfunction by using Charlson Comorbidity Index, M.S. Silay*, H. Sirin, O. Tanriverdi, T. Karatag, M. Aydın, C. Miroglu, M. Kendirci (Istanbul, Turkey)
        C34.Quality of life in men with prostatic cancer and related erectile dysfunction, C.N. Manea*, N. Crisan, B.O. Feciche, Z. Mihaly, C. Giurgiu, J. Babak, D. Stanca, C. Hurubeanu, C. Lapusan, I. Coman (Cluj Napoca, Dej, Romania)
        C35.Erectile function of male patients at a Central European urology outpatient clinic, M. Benyó*, G. Csanádi, E. Balogh, Cs. Berczi, Zs. Molnár, A. Varga, T. Flaskó (Debrecen, Hungary)
        C36.Do serotonin re-uptake inhibitors affect directly the smooth muscle of the human seminal vesicle? A functional and molecular biology study, P. Birowo, S. Ückert*, J.E. Sonnenberg, D. Rahardjo, M.A. Kuczyk (Jakarta, Indonesia; Hannover, Germany)
        C37.Clinical parameters and spermiogram analysis in 716 Austrian patients with varicocele, B. Mohamad Al-Ali*, K. Pummer, H. Trummer (Graz, Austria)
        C38.Serum homocysteine levels and spermiogram quality after three months of oral vitamin supplementation, B. Mohamad Al-Ali*, M. Marszalek, K. Pummer, H. Trummer (Graz, Vienna, Austria)
        C39.Prevalence of testosterone deficiency syndrome (TDS), erectile dysfunction (ED) and metabolic syndrome (MS) in men over 50 yr with abdominal obesity in Slovakia, L. Fillo*, J. Breza, J. Levcikova, A. Vachulova (Bratislava„ Slovakia)
        C40.The outcome of scrotal exploration, microsurgical reconstruction and sperm harvesting in patients with primary obstructive azoospermia – first results, I. Sinescu, S. Voinea*, M. Harza, I. Manea, B. Haineala, C. Gagiu, A. Preda, M. Matei, G. Dohle (Bucharest, Romania; Rotterdam, The Netherlands)
        C41.Short term results after microscopic subinguinal varicocelectomy for male infertility, I. Sinescu, S. Voinea*, M. Harza, I. Manea, B. Haineala, C. Gagiu, A. Preda, M. Matei, G. Dohle (Bucharest, Romania; Rotterdam, The Netherlands)
        C42.Sexual dysfunction and testosterone deficiency in obstructive sleep apnea syndrome (OSAS) patients, B.S. Bercea*, R. Bercea, E. Cojocaru, T. Mihaescu (Iasi, Romania)
        C43.Inflammatory markers of andrology, Z. Kopa*, J. Nemeth, K. Miklos, Z. Szabó (Budapest, Hungary)
        C44.Does successful treatment of erectile dysfunction improve quality of life?, J. Bizjak*, M. Ravnik-Oblak, I. Bizjak, N. Arnerić, C. Oblak, B. Štrus (Ljubljana, Celje, Slovenia)
        C45.Cross-sectional, controlled epidemiological study investigating erectile dysfunction and late onset hypogonadism in leprosy patients, H. Guler, M.S. Silay*, M. Kadihasanoglu, O. Tanriverdi, M. Aydın, C. Miroglu, M. Kendirci (Istanbul, Turkey)
        C46.Transrectal ultrasonography of prostate, serum levels of PSA and testosterone and long term hormonal substitution therapy in patients with Kallmann syndrome, K. El Balouly*, J. Heráček, M. Snajderova, D. Zemkova, F. Zatura, M. Urban (Prague, Olomouc, Czech Republic)
        C47.Salvage retroperitoneal lymphadenectomy after multiple chemotherapy regimens for nonseminomatous testicular tumors, D. Argirovic*, A. Argirovic, V. Stanic (Belgrade, Serbia)
        C48.The long-term side effects of adjuvant radiotherapy vs carboplatin chemotherapy in clinical stage A seminomatous testicular tumors, D. Argirovic*, L. Jelic-Radosevic, A. Argirovic (Belgrade, Serbia)
        C49.The management of nonseminomous germ cell tumors of testis (NSGCT) stage I with stable increase of tumor markers, A.V. Sakalo*, P.G. Yakovlev, S.V. Samojlenko (Kiev, Ukraine)
        C50.Testicular tumour – a review of management, A. Hameed*, B. White, N. Al Saffar (London, Middlesbrough, Ayr, United Kingdom)
        Tabled 1
        12.30–13.30Lunch
        13.30–14.30Male incontinence
        Rational diagnostic work up, R. Zachoval, Prague (CZ)
        Management of the overactive bladder, J. Svihra, Martin (SK)
        Management of iatrogenic incontinence, C. Oblak, Ljubljana (SI)
        14.30–14.50Coffee break and poster viewing
        Tabled 1
        14.30–16.30Posters session 4: Benign and Malignant renal diseases and Kidney transplantPoster room 1
        C51.Nephron sparing surgery for renal cancer – expanding indications and advancement in minimal invasive surgery, T. Ürge*, P. Stránský, M. Hora, O. Hes, V. Eret, J. Ferda, Z. Chudáček (Plzeň, Czech Republic)
        C52.Prognostic factors and survival of clear cell renal carcinoma patients with bone metastasis, A. Szendrï*, E. Dinya, A.M. Szasz, Zs. Németh, M. Kardos, J. Kiss, K. Ats, I. Antal, A. Szendrői, I. Romics (Budapest, Hungary)
        C53.Risk factors in renal cell carcinoma with venous extension, C. Gingu*, S. Patrascoiu, C. Chibelean, C. Surcel, M. Harza, M.A. Manu, V. Cerempei, D. Tica, C. Balsanu, I. Sinescu (Bucharest, Romania)
        C54.Management of renal oncocytoma – a single centre experience, I. Sinescu, M.A. Manu*, C. Gingu, R. Varsandan, V. Mitroi, M. Lisa, R. Manu, C. Surcel, R. Lazar, C. Savu, M. Mihai, M. Hortopan (Bucharest, Romania)
        C55.The impact of selected surgical approach on postoperative morbidity in the management of advanced renal cell carcinoma (pT3, pT4), J. Sachová*, P. Palascak, M. Urban, W. Gomez-Orozco, J.L. Sauvain, N. Nader (Prague, Czech Republic; Vesoul, France)
        C56.Characteristics of dendritic cells and regulatory T-lymphocytes in the blood and tumor tissue in patients with renal cell carcinoma, I. Minárik*, J. Lašt’ovička, V. Budínský, I. Kawaciuk, J. Bartůňková (Prague, Czech Republic)
        C57.Histological finding of the tumor necrosis in the renal cancer specimen as a negative prognostic factor, J. Pacovský*, M. Brodak, L. Holub, P. Hušek, J. Košina, P. Navratil, M. Podhola (Hradec Kralove, Czech Republic)
        C58.Spontaneous rupture of the renal pelvis, M. Chocholatý*, M. Schmidt, P. Hanek, L. Jarolím, I. Kawaciuk (Prague, Czech Republic)
        C59.Image fractal analysis in retroperitoneal fibrosis – 5 years of experience with 19 patients, I. Sinescu, C. Surcel*, C. Mirvald, C. Chibelean, C. Gingu, D. Avram, M. Hîrza, M.A. Manu, R. Lazar, C. Savu, A. Udrea (Bucharest, Romania)
        C60.Lymphocele after kidney transplantation, J. Breza Jr.*, Z. Zilinska, C. Martin, P. Bujdak, J. Breza (Bratislava, Slovakia)
        C61.The ureter in patients after kidney transplantation, J. Breza Jr.*, Z. Zilinska, P. Bujdak, J. Breza (Bratislava, Slovakia)
        C62.Comparative study regarding quality of life assessed by SF-36 health survey in older versus younger and related versus non-related live kidney donors, I. Sinescu, M. Harza, B. Stefan, C. Baston, V. Cerempei, M.A. Manu*, R. Lazar, D. Tacu, E. Kerezsy, C. Bucsa, L. Domnisor, D. Daia, O. Palea, E. Burchiu (Bucharest, Romania)
        C63.Early graft dysfunction due to vascular anomalies, vessels reconstruction and special anastomotic techniques in kidney transplantation, I. Sinescu*, M. Harza, B. Serbanescu, B. Stefan, C. Baston, V. Cerempei, M.A. Manu, D. Tacu, E. Kerezsy, C. Bucsa, L. Donnisor, D. Daia, O. Palea, E. Burchiu, I. Constantinescu (Bucharest, Romania)
        C64.The impact of slow and delayed graft function vs. immediate graft function on cadaver renal transplant outcomes, I. Sinescu, M. Harza, B. Serbanescu, B. Stefan, C. Baston, V. Cerempei, M.A. Manu*, R. Lazar, D. Tacu, E. Kerezsy, C. Bucsa, L. Domnisor, D. Daia, O. Palea, E. Burchiu, I. Constantinescu (Bucharest, Romania)
        C65.Preoperative evaluation, management and surgical aproach in non conventional kidney transplantation due to graft vascular anomalies – 12 years single center experience, I. Sinescu*, M. Harza, B. Serbanescu, B. Stefan, C. Baston, V. Cerempei, M.A. Manu, D. Tacu, E. Kerezsy, C. Bucsa, L. Domnisor, D. Daia, O. Palea, E. Burchiu, I. Constantinescu (Bucharest, Romania)
        C66.Our experience with bladder cancer in patients after kidney transplantation, L. Holub*, J. Pacovský, P. Navratil, M. Brodak, J. Košina, P. Hušek (Hradec Kralove, Czech Republic)
        Tabled 1
        14.30–16.30Posters session 5: NephrolithiasisPoster room 2
        C67.Ureteroscopic instrument damage; experience after 5,500 ureteroscopies, D.A. Georgescu*, V. Mirciulescu, V. Cauni, G. Nita, R. Multescu, C. Persu, B. Geavlete, P. Geavlete (Bucharest, Romania)
        C68.Migrated and calcified ureteral stents: A challenging problem (experience on 125 cases), I. Arabagiu*, D. Georgescu, V. Cauni, V. Mirciulescu, G. Nita, R. Multescu, C. Persu, E. Alexandrescu, B. Geavlete, P. Geavlete (Bucharest, Romania)
        C69.Ureteroscopy in proximal ureteral calculi: experience on 1238 cases, E. Alexandrescu*, V. Cauni, D.A. Georgescu, G. Nita, V. Mirciulescu, R. Multescu, M. Dragutescu, B. Geavlete, P. Geavlete (Bucharest, Romania)
        C70.Complications after 2000 percutaneous procedures, V. Mirciulescu*, V. Cauni, D.A. Georgescu, G. Nita, R. Multescu, M. Dragutescu, P. Geavlete (Bucharest, Romania)
        C71.Bilateral single procedure percutaneous nephrolithotomy, V. Mirciulescu*, V. Cauni, D. Georgescu, E. Alexandrescu, P. Geavlete (Bucharest, Romania)
        C72.Ureterorenoscopy in treating ureteral calculi: experience of Croatian Reference Center for Urolithiasis, B. Sudarević*, H. Kuvezdic, D. Simunovic, J. Galic (Osijek, Croatia)
        C73.Conventional fiberoptic flexible ureteroscope vs. 4th generation digital flexible ureteroscope: a critical comparison, R. Multescu*, B. Geavlete, P. Geavlete (Bucharest, Romania)
        C74.Flexible ureterorenoscopy for kidney stones, our experience with 46 patients, P. Dancik*, V. Kosar, R. Kuldan (Ostrava, Czech Republic)
        C75.PNL in the treatment of staghorn calculi – a 15 years experience, V. Ambert*, M.T. Radu, B. Braticevici, Y. Sallahedin, V. Voinescu, T.V. Constantin (Bucharest, Romania)
        C76.Forgotten double j catheters – a rare but challenging-to-treat pathology, V. Ambert*, B. Braticevici, Y. Sallahedin, M.T. Radu, T.V. Constantin (Bucharest, Romania)
        C77.Percutaneous nephrolithotomy (PNL) in the treatment of lithiasis developed on congenital renoureteral abnomalities – The 12 year experience of the Clinic of Urology, “Prof. Dr. Th. Burghele” Clinical Hospital, Bucharest, Romania, V. Ambert*, B. Braticevici, V. Voinescu, Y. Sallaheddin, V. Jinga, M.T. Radu, T.V. Constantin (Bucharest, Romania)
        C78.PNL on solitary kidney – a 10 years experience, V. Ambert*, B. Braticevici, Y. Sallahedin, V. Voinescu, T.V. Constantin, M.T. Radu (Bucharest, Romania)
        C79.ESWL for treatment of lower pole caliceal stone, N. Rexha*, A. Jusufi, A. Hoxha, A. Hazrolli, S. Rexha (Gjakove, Gjakova, Kosovo)
        C80.Results of ESWL treatment for residual stones after primary PNL approach in struvite staghorn lithiasis, V. Ambert, I.D. Chira*, B. Braticevici, V. Jinga, Y. Salah Edin, T. Radu (Bucharest, Romania)
        C81.Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system, V. Ambert, B. Braticevici, Y. Salaheddin, R.C. Petca*, L. Hainagiu, D. Diaconescu, A. Chuaibi, M. Mansour, C. Calin, S. Andrei (Bucharest, Romania)
        C82.Urinary calculus and artificial sample fragmentation during Er:YAG and Ho:YAG lithotripsy in vitro, J. Pokorný*, O. Köhler, T. Hanuš, P. Koranda, H. Jelínková, M. Němec, M. Urban, R. Grill (Prague, Czech Republic)
        C83.Working hard in a small-volume center: Our experiences with percutaneus nephrolithotomy, D. Simunovic*, B. Sudarević, H. Kuvezdic, D. Koprolcec, J. Galic (Osijek, Croatia)
        C84.Destruction of stones in the kidney, bladder and ureter without harming catheter and basket material using an innovative low-energy laser shockwave mode, J. Neymeyer*, W. Abdul-Wahab Al-Ansari, T. Wuelfing, A. Apostolidis, C. Baecker, M. Beer (Berlin, Germany)
        C85.Biological effects of extracorporeal shock wave lithotripsy, B. Mohamad Al-Ali*, K. Pummer, M. Auprich (Graz, Austria)
        C86.Digital semirigid ureteroscopy: a new standard in endoscopic imaging, D.R. Multescu*, V. Mirciulescu, B. Geavlete, P. Geavlete (Bucharest, Romania)
        Tabled 1
        14.30–16.30Posters session 6: Prostate cancerPoster room 3
        C87.Balance between apoptotic and proliferative tissue markers in prostate cancer needle biopsies correlates with stage and Gleason score, M. Munda*, T. Hajdinjak, R. Kavalar, D. Štiblar-Martinčič (Maribor, Slovenia)
        C88.Active surveillance in prostate cancer – save option when knowing postoperative staging and grading? Single institution experience from 2003–2009, M. Kral*, D. Kurfurstova, V. Student, M. Hrabec, M. Grepl, A. Vidlar, P. Kratochvil, V. Rosinska (Olomouc, Czech Republic)
        C89.Hormone naive patients with advanced prostate cancer have lower initial BMD than healthy controls, S. Ziaran*, F.M. Goncalves, J. Stefancik, J. Hoffmann, J. Breza Sn. (Bratislava, Slovakia)
        C90.Influence of the operative technique on the incidence of incidental prostatic carcinoma, D. Kotlar*, D. Simunovic, Z. Filipan, T. Dujmovic, D. Stajcar (Vukovar, Osijek, Varazdin, Croatia)
        C91.Prostate brachytherapy with permanent iodine (125I) seed implant (LDR) – intermediate biochemical results and complications, M. Harza*, C. Dudu, A. Iordache, S. Voinea, C. Pavel, C. Gingu, B. Serbanescu, C. Chibelean, C. Surcel, A. Preda, C. Baston, B. Stefan, B. Haineala, R. Anghel, M. Vasile, L. Domnisor, L. Rebegea, M.F. Radulescu, I. Sinescu (Bucharest, Galati, Romania; Saarbrucken, Germany)
        C92.The advantages of using the transrectal biplane transducer with 3D reconstruction for prostate explorations, V. Ambert*, V. Jinga, M.T. Radu, T.V. Constantin, D. Badescu, A.H. Ateia (Bucharest, Romania)
        C93.The role of adipocytokines in prostate cancer, F. Rusu, V. Madan*, E. Rusu, A. Dragomir, G. Radulian, D. Cheta, D. Mischianu (Bucharest, Romania)
        C94.Anastomotic stricture after radical prostatectomy – risk factors, O. Čapoun*, M. Babjuk, J. Dvoracek, T. Hanuš, L. Safarik, I. Pavlik, K. Novak (Prague, Czech Republic)
        C95.Reevaluation of Gleason score, extraprostatic extension and surgical margins status on radical prostatectomy specimens: learning curve in uropathology, B. Pospihalj*, M. Zupančič, F. Kramer (Slovenj Gradec, Slovenia)
        C96.Follow-up of patients with accidental finding of infiltration of pelvic lymph nodes after radical prostatectomy, P. Hušek*, M. Brodak, J. Pacovský, J. Košina, L. Holub (Hradec Kralove, Czech Republic)
        C97.Comparison of clinical and pathological features between prostate cancers detected by the first biopsy and by re-biopsy with an extended scheme, H. Augustin*, M. Auprich, G. Gallé, S. Gutschi, B. Mohamad Al-Ali, R. Peteani, S. Mannweiler, K. Pummer (Graz, Austria)
        C98.Two generations of Partin Tables: Comparison of predictive accuracy, H. Augustin*, M. Auprich, G. Gallé, S. Gutschi, B. Mohamad Al-Ali, D. Bonstingl, S. Mannweiler, K. Pummer (Graz, Austria)
        C99.Occurrence of prostate cancer in patients with muscle-invasive bladder cancer after radical cystoprostatectomy, J. Košina*, M. Brodak, M. Louda, J. Pacovský, L. Holub, P. Hušek, M. Romžová (Hradec Kralove, Czech Republic)
        C100.Lateral decubitus position is less painful than lithotomy position for patients undergoing prostate biopsy, B. Lodeta*, M. Lodeta, G. Benko, Z. Filipan, D. Stajcar, T. Dujmovic (Varazdin, Varazdinske Toplice, Croatia)
        C101.Detection of ETS translocations using Affymetrix exon 1.0 ST arrays, F.P. Smit, M. Salagierski*, J.A. Schalken (Nijmegen, The Netherlands; Lodz, Poland)
        Tabled 1
        16.30–17.00Debate. Prostate cancer: Is active surveillance a valid option?
        Chair: M.Marberger, Vienna (AT)
        Pro: T. Demkow, Warsaw (PL)
        Contra: I. Romics, Budapest (HU)
        17.00–18.00Symposium
        Sponsored by GE HEALTHCARE

        Saturday, 24 October 2009

        Tabled 1
        08.00–09.00Update on Infections Disease
        Sexually transmitted disease, O. Kraus, Zagreb (CRO)
        Nosocomial Infections, L. Valansky, Kosice (SK)
        Urogenital tuberculosis – “forgotten pathology” in Central European countries? P. Geavlete, Bucharest (RO)
        09.00–09.20State-of-the-art: Update on penile cancer
        P. Nyirady, Budapest (HU)
        09.20–09.50Coffee break and poster viewing
        Tabled 1
        09.20–11.30Poster session 7: Laparoscopy and Reconstructive surgeryPoster room 1
        C102.Complete laparoscopic nephroureterectomy, M. Hora, E. Eret*, T. Ürge, J. Klečka, P. Stránský, O. Hes, Z. Chudáček, J. Ferda (Plzeň, Czech Republic)
        C103.Strictures of urethrovesical anastomosis after laparoscopic radical prostatectomy: Risk factors and treatment options, Z. Krstanoski*, M. Zupančič, N. Vodopija, F. Kramer, L. Koršič, I. Parać (Slovenj Gradec, Slovenia)
        C104.Laparoscopic nephrectomy for advanced renal tumours (cT2 >8 cm, cT3a–b, cN+), V. Eret*, M. Hora, O. Hes, J. Ferda, J. Klečka, P. Stránský, T. Ürge, Z. Chudáček (Plzen, Czech Republic)
        C105.Extraperitoneal laparoscopic radical prostatectomy: Evaluation of learning curve, M. Zupančič*, F. Kramer, Z. Krstanoski, L. Koršičc, I. Parać, N. Vodopija (Slovenj Gradec, Slovenia)
        C106.Possibilities of reconstructing the vesicourethral anastomosis during laparoscopic radical prostatectomy, J. Fejfar*, M. Štursa, L. Janiš (Novy Jicin, Czech Republic)
        C107.Laparoscopic assisted radical cystectomy – our initial experience, F. Kramer*, M. Zupančič, L. Koršič, Z. Krstanoski, I. Parać (Slovenj Gradec, Slovenia)
        C108.Laparoscopic adrenalectomy – 10-years experience in a single institution, I. Hartmann*, V. Student, M. Kral, O. Smakal, M. Hrabec, M. Grepl (Olomouc, Czech Republic)
        C109.Laparoscopic and open partial nephrectomy: a matched pair comparison of 200 patients, M. Marszalek*, H. Meixl, M. Polajnar, M. Rauchenwald, S. Madersbacher, K. Jeschke (Vienna, Klagenfurt, Austria)
        C110.Laparoscopic heminephrectomy in adult patients – initial experience, T. Borkowski*, J. Michalec, E. Bres (Warsaw, Poland)
        C111.Endoscopic extraperitoneal radical prostatectomy (EERPE): a retrospective analysis of 128 patients, N. Morakis*, P.F. Engelhardt, C. Riedl (Baden, Austria)
        C112.The 16-dot-plication technique for correction of penile curvature – initial result, S. Voinea*, C. Gingu, I. Manea, B. Haineala, A. Preda, C. Pavel, A. Iordache, C. Gagiu, M. Harza, I. Sinescu (Bucharest, Romania)
        C113.10 years experience with bipolar approach in complete urethral strictures, D. Soroiu*, D.A. Georgescu, R. Multescu, V. Cauni, V. Mirciulescu, G. Nita, P. Geavlete (Bucharest, Romania)
        C114.Management of posterior urethral distraction injury, J. Bizjak, S. Poteko*, K. Jagodič (Celje, Slovenia)
        C115.Outcomes of dorsal inlay graft TIPU technique in primary hypospadias repair: Prospective clinical study investigating early and late-term urine flow measurements, M.S. Silay*, H. Sirin, T. Karatag, O. Tanriverdi, M. Kadihasanoglu, K. Horasanli, C. Miroglu (Istanbul, Turkey)
        C116.Primary management of the posterior urethra by traction over the Foley catheter in patients with pelvic fractures, M.K. Rebek*, A. Kruscic, D. Bratuš, G. Hlebič, A. Kolenc, M. Križančič (Maribor, Slovenia)
        Tabled 1
        09.20–11.30Poster session 8: Bladder cancer, Urinary diversion and Pediatric urologyPoster room 2
        C117.Prognostic value of gene PAX5 expression in the Ta,T1 urothelial urinary bladder carcinoma, V. Soukup*, M. Babjuk, M. Pešl, M. Szakácsová, L. Zámečník, T. Hanuš, J. Mareš, O. Čapoun (Prague, Czech Republic)
        C118.Nuclear matrix protein 22 urinary marker in diagnosing and follow up of urinary bladder tumors, T. Smrkolj*, M. Mihelic, A. Sedlar, I. Sterle, J. Osredkar, B. Sedmak (Ljubljana, Slovenia)
        C119.Second TURB in non-muscle invasive bladder cancer – experience on 400 cases, D.A. Georgescu*, V. Cauni, R. Multescu, G. Nita, B. Geavlete, P. Geavlete (Bucharest, Romania)
        C120.Recurrence rates in high-risk non-muscle invasive bladder tumors – the real impact of HAL blue light fluorescence cystoscopy and TURB, B. Geavlete*, M. Jecu, R. Multescu, D.A. Georgescu, P. Geavlete (Bucharest, Romania)
        C121.Urinary cytology and cystoscopy in recurrent bladder tumors, G. Glück*, L. Neagoe, R. Andrei, A. Filip, A. Iordache, I. Sinescu (Bucharest, Romania)
        C122.Early post TURB instillational treatment in Ta,T1 bladder cancers, G. Glück*, R. Stoica, L. Neagoe, R. Andrei, A. Filip, A. Iordache, I. Sinescu (Bucharest, Romania)
        C123.The value of adjuvant instillational treatments in outcomes of Ta,T1 bladder cancers, G. Glück*, R. Stoica, L. Neagoe, R. Andrei, A. Filip, A. Iordache, I. Sinescu (Bucharest, Romania)
        C124.NK cell immunohistochemistry – a new prognostic marker of bladder cancer recurrence?, K. Krpina*, E. Sinozic, G. Djordjevic, N. Jonjic, Z. Fuckar (Rijeka, Croatia)
        C125.A critical analysis of perioperative mortality and morbidity from radical cystectomy, B. Braticevici, V. Ambert, D. Damian, S. Andrei*, I. Chira, L. Hainagiu, R. Petca, D. Radavoi, F. Bengus (Bucharest, Romania)
        C126.Validation of the Memorial Sloan-Kettering Cancer Center (MSKCC) postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer, J. Pokorný*, M. Urban, R. Grill, J. Heráček, J. Poch, T. Baitler, V. Mašková, J. Sachová, Z. Otava, T. Novotný, L. Bittner, Z. Trnĕná, J. Hrbáček (Prague, Czech Republic)
        C127.The comparative investigation of perineal muscle functions after Mainz pouch type II distraction of urine following radical cystectomy or after radical prostatectomy surgeries, A.L. Keszthelyi*, A. Majoros, S. Mavrogenis, I. Asztalos, L. Keszthelyi, I. Romics (Budapest, Hungary)
        C128.Managing the retroperitoneal tumors – 20 years single center experience, I. Sinescu, M.A. Manu*, C. Gingu, R. Varsandan, V. Mitroi, M. Lisa, R. Manu, C. Surcel, R. Lazar, C. Savu, M. Mihai, M. Hortopan (Bucharest, Romania)
        C129.The androgen status of the appendix testis determines the effect of hormonal treatment in cryptorchidism, G. Drabik*, A. Telek, B. Dienes, O. Ruzsnavszky, I. Kovács, T. Flaskó, G. Balla, C. Kiss, T. Józsa (Debrecen, Hungary)
        C130.Two stage hypospadias cripples buccal mucosa graft repair, C. Gingu*, S. Patrascoiu, C. Chibelean, C. Surcel, M. Harza, M.A. Manu, V. Cerempei, D. Tica, C. Balsanu, I. Sinescu (Bucharest, Romania)
        C131.Surgical treatment of varicocele in children with open suprainguinal microscopic lymphatic sparing varicocelectomy, M. Drlik*, S. Tichy (Prague, Czech Republic)
        C132.Experience in cryptorchidism and retractile testicles surgery at the Department of Urology of University hospital Osijek: a ten-year review, I. Radoja*, I. Perkovic, D. Simunovic, J. Galic (Osijek, Croatia)
        C133.The incidence and management of crossing vessels in children with pyeloureteral obstruction, B. Sulya*, M. Sajthy, A. Kiss, M. Merksz (Budapest, Hungary)
        C134.Hinman-Allen syndrome: Is it safe to perform augmentation in high risk patients? A comparative study with long term follow-up, M.S. Silay*, O. Tanriverdi, T. Karatag, M. Aydın, M. Kadihasanoglu, K. Horasanli, C. Miroglu (Istanbul, Turkey)
        Tabled 1
        11.30–11.40EUSP Lecture
        T. Kalogeropoulos, Athens (GR)
        11.30–12.30Panel discussion. T3 prostate cancer: Radiotherapy or radical prostatectomy
        Chair: O. Zechner, Vienna (AT)
        Radiotherapy, E. Senkus, Gdańsk (PL), P. Agoston, Budapest (HU)
        Radical prostatectomy, P.A. Abrahamsson, Malmo (SE), L. Jarolim, Prague (CZ)
        12.30Awards and closing remarks
        C. Oblak, Ljubljana (SI)
        M. Marberger, Vienna (AT)
        13.00–18.00ESRU Autumn Meeting